• Nenhum resultado encontrado

Rev. Bras. Anestesiol. vol.67 número1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Anestesiol. vol.67 número1"

Copied!
13
0
0

Texto

(1)

REVISTA

BRASILEIRA

DE

ANESTESIOLOGIA

PublicaçãoOficialdaSociedadeBrasileiradeAnestesiologia

www.sba.com.br

REVIEW

ARTICLE

Benefit

of

general

anesthesia

monitored

by

bispectral

index

compared

with

monitoring

guided

only

by

clinical

parameters.

Systematic

review

and

meta-analysis

Carlos

Rogério

Degrandi

Oliveira

a,b,∗

,

Wanderley

Marques

Bernardo

c,d,e

,

Victor

Moisés

Nunes

d

aHospitalGuilhermeAlvaro,DepartamentodeAnestesiologia,Santos,SP,Brazil

bHospitalAnaCosta,DepartamentodeAnestesiologia,Santos,SP,Brazil

cUniversidadedeSãoPaulo,FaculdadedeMedicina,MedicinaBaseadaemEvidência,SãoPaulo,SP,Brazil

dCentroUniversitárioLusíada,FaculdadedeMedicinadeSantos,Santos,SP,Brazil

eProgramaDiretrizesdaAssociac¸ãoMédicaBrasileira,Santos,SP,Brazil

Received14July2015;accepted22September2015 Availableonline14April2016

KEYWORDS Generalanesthesia; Anesthetics; Inhalation; Intravenous anesthesia; Bispectral index-monitoring

Abstract

Background: Thebispectralindexparameterisusedtoguidethetitrationofgeneralanesthesia; however,manystudieshaveshownconflictingresultsregardingthebenefitsofbispectralindex monitoring.Theobjectiveofthissystematicreviewwithmeta-analysisistoevaluatetheclinical impactofmonitoringwiththebispectralindexparameter.

Methods:The search for evidence in scientific information sources was conducted during December2013toJanuary 2015,thefollowing primarydatabases:Medline/PubMed,LILACS, Cochrane,CINAHL,Ovid,SCOPUSandTESES.Thecriteriaforinclusioninthestudywere random-izedcontrolledtrials,comparinggeneralanesthesiamonitored,withbispectralindexparameter withanesthesiaguidedsolelybyclinicalparameters,andpatientsagedover18years.The crite-riaforexclusionwerestudiesinvolvinganesthesiaorsedationfordiagnosticprocedures,and intraoperativewake-uptestforsurgeryofthespine.

Results:The use ofmonitoringwith thebispectralindex hasshown benefits reducing time to extubation,orientation in timeand place, anddischarge from boththe operating room andpostanestheticcareunit.Theriskofnauseaandvomitingaftersurgerywasreducedby 12% inpatients monitoredwith bispectralindex.Occurred areductionof3% inthe riskof cognitiveimpairmentpostoperativelyat3monthspostoperativelyand6%reductionintherisk ofpostoperativedeliriuminpatientsmonitoredwithbispectralindex.Furthermore,theriskof intraoperativememoryhasbeenreducedby1%.

Correspondingauthor.

E-mail:[email protected](C.R.Oliveira). http://dx.doi.org/10.1016/j.bjane.2015.09.001

(2)

Conclusion: Clinically,anesthesiamonitoringwith theBIScanbe justifiedbecauseitallows advantagesfromreducingtherecoverytimeafterwaking,mainlybyreducingtheadministration ofgeneralanestheticsaswellastheriskofadverseevents.

©2016SociedadeBrasileiradeAnestesiologia.Publishedby ElsevierEditoraLtda.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/).

PALAVRAS-CHAVE Anestesiageral; Anestésicos; Inalac¸ão; Anestesia intravenosa; Monitorac¸ãodo índicebispectral

Benefíciodaanestesiageralcommonitorac¸ãodoíndicebispectralemcomparac¸ão comomonitoramentoguiadoapenasporparâmetrosclínicos.Revisãosistemáticae metanálise

Resumo

Justificativa: Oparâmetroíndicebispectral(BIS)éusadoparaguiaratitulac¸ãodaanestesia geral;noentanto,muitosestudostêmmostradoresultadosconflitantesquantoaosbenefícios damonitorac¸ãodoBIS. Oobjetivodestarevisão sistemáticacommeta-análisefoi avaliaro impactoclínicodamonitorac¸ãodoparâmetroBIS.

Métodos: Abuscaporevidênciasemfontesdeinformac¸ãocientíficasfoiconduzidadedezembro de2013ajaneirode2015nasseguintesbasesdedados:Medline/PubMed,LILACS,Cochrane, CINAHL,Ovid,SCOPUSeTESES.Oscritériosdeinclusãoforamestudosrandomizadose controla-dos,comparandoanestesiageralmonitoradacomoparâmetroBIScomanestesiaguiadaapenas porparâmetrosclínicosempacientescomidadesuperiora18anos.Oscritériosdeexclusão foramestudosqueenvolveramanestesiaousedac¸ãoparaprocedimentosdediagnósticoeteste dedespertarnointraoperatóriodecirurgiadacolunavertebral.

Resultados: Ousodemonitorac¸ãocomoBISmostroubenefícioscomoareduc¸ãodotempode extubac¸ão,orientac¸ãonotempoenoespac¸o,altadasaladecirurgiaedasaladerecuperac¸ão pós-anestesia.Oriscodenáuseasevômitosnopós-operatóriofoireduzidoem12%empacientes monitorados comoBIS.Ocorreuumareduc¸ãode3%noriscodedisfunc¸ãocognitivaemtrês mesesdopós-operatórioe6%noriscodedelíriopós-operatórioempacientesmonitoradoscom oBIS.Alémdisso,oriscodedespertarcommemóriaintraoperatóriafoireduzidoem1%. Conclusão:Clinicamente, amonitorizac¸ãocomoBISpodeserjustificada,poispermite van-tagens em reduzir o tempo de recuperac¸ão, principalmente reduzindo a administrac¸ão de anestésicosgeraiseoriscodeeventosadversos.

©2016SociedadeBrasileiradeAnestesiologia.PublicadoporElsevierEditoraLtda.Este ´eum artigo OpenAccess sobumalicenc¸aCCBY-NC-ND( http://creativecommons.org/licenses/by-nc-nd/4.0/).

Introduction

Bispectral index (BIS) is a multiprocessor EEG parameter

specially developedtomeasure theeffects ofanesthetics

on the brain hypnotic state, making it possible to

mea-sure the depthof anesthesia. The introduction of the BIS

in clinical practice is a reliable method to assess brain

function and allows the titrationof hypnotics on cortical activity.

Duetoanesthesiamayoccurunpredictableresponsesat

different times of surgery with a great variability among

patients,sotheexactdosageof anesthetictobe adminis-teredstillremainsachallenge.However,manystudieshave

shown conflicting results regarding the advantages of BIS

andifthismonitoringimprovesrecoverytimesandhospital discharges,aswellasminimizesadverseevents.

The objective of this systematic review with

meta-analysis was to clinically evaluate the objective BIS

monitoring parameter, comparedwith the clinical

param-etersingeneralanesthesia.

Methods

The research for evidence in scientific sources of

infor-mation was performed by two independent reviewers

(CRDO, WMB) during the period from December 2013

to January 2015, the following primary databases:

Med-line/PubMed, LILACS, Cochrane, CINAHL, Ovid, SCOPUS

and THESES. The search strategy was made with the

following words: (Anesthesia, General OR Anesthetics,

InhalationORAnesthetics,Intravenous)AND(Consciousness MonitorsORMonitoring,IntraoperativeORBispectral

index-monitoring technology OR Bispectral index-monitoring OR

BispectralindexmonitoringORDrugMonitoringOR

Aware-ness OR Monitoring, Physiologic OR BIS monitoring) AND

Random*.

ThecriteriaforinclusioninthestudywereRandomized

ControlledTrials(RCTs)withlevelofevidence1B/2B(Oxford CentreforEvidence-basedMedicine)inEnglish,Spanishor

Portugueselanguages,comparingvenousorinhaledgeneral

(3)

Table1 Consideredoutcomes. Timeforspontaneouseyeopening

Timeforeyeopeninguponverbalcommand Timetotrachealextubation

Timefororientationintimeandplace Timeforleavingoperatingroom

Timefordischargefrompostanesthesiacareunit(PACU) Timeforhospitaldischarge

Postoperativenauseaandvomiting(PONV) Cognitivedisordersinthepostoperativeperiod (1weekafterextubation)

Cognitivedisordersinthepostoperativeperiod (3monthsafterextubation)

Postoperativedelirium Intraoperativememory

guidedsolelybyclinicalparameters;patientsagedover18 years.

Thecriteriaforexclusionwerestudiesinvolving anesthe-siaandsedationfordiagnosticprocedures.Studiesinvolving intraoperativewake-up testfor surgery ofthe spinewere excluded. Nor were objects of study the clinical trials of ketamineasvenousanesthetic.

Thissystematicreviewwithmeta-analysiswasrecorded inPROSPEROdatabaseunderthenumberCRD42015017240.

TheoutcomesconsideredaredescribedinTable1.

The results of the meta-analysiswere obtainedby the

RevMan5.2software(Review ManagerComputerprogram.

Version 5.2 Copenhagen: The Nordic Cochrane Centre,

CochraneCollaboration©2014).

Regarding meta-analysis, the difference was

calcu-lated in risk difference for dichotomic variables with

Mantel---Haenszel (M-H) test with95%ConfidenceInterval; andinmeandifferencewithfixedeffectusingInverse

Vari-ance (IV), witha 95% Confidence Interval,for continuous

variables.

An I2 of 0% indicates no heterogeneity among studies,

valuesbelow50%indicatealowheterogeneity,andabove

50%,highheterogeneity.

Whentheheterogeneitywasgreaterthan50%,a sensitiv-ityanalysiswasperformed,removingthestudiesthatwere out ofthe ‘‘forestplot’’. To achievereductionin

hetero-geneityremainedoutofthestudymeta-analysis.

Results

Initially,thesearchresultedin1.747scientificarticles.After applyingtheinclusionandexclusioncriteriawereselected 17RCT(Fig.1).

Table2showsthetrialsselectedwiththerespective

lev-elsofevidence,Jadadscale,numberofpatientsrandomized andanalyzed,patientnumbersintheinterventionand con-trolgroupsandPICOstrategy.Atotalof10,761patientswere

analyzed, 5668 in the intervention groupand 5093 in the

controlgroup.

Table3showsthe36full-textarticlesexcludedwith

rea-sons.

Thetimefor spontaneouseye openingis countedfrom

theendofthelastsuture,whentheninhaledorintravenous

anesthetic is discontinued. The monitoring with the BIS,

compared exclusively with clinical parameters, showed a

reduction in the time for spontaneous opening 0.62min

eye (95% CI−1.08, −0.16), withan I2=83%.In sensitivity

analysis, when removed the study Kreuer et al.7 was

removed we have an I2=0%, with reduction of time for

Records identified through database searching

(n=1744)

Additional records identified through other sources

(n=3)

Records excluded (n=1694) Records screened

(n=1747)

Full-text articles assessed for eligibility

(n=53)

Full-text articles excluded, with reasons

(n=36)

Studies included in qualitative synthesis

(n=17)

Studies included in quantitative synthesis

(meta-analysis) (n=17)

(4)

Table2 Selectedrandomizedclinicaltrials(RCT).

RCT EL J R/A I/C P I C O

Nelskyläetal. (2001)1

2B 0 62/62 32/30 ASAIorII,

between18and50 years,

gynecological surgery.

BISbetween50 and60years

‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye opening, extubation, orientationintime andplace,hospital dischargeand PONV. Wongetal.

(2002)2

1B 3 68/60 29/31 >60years,ASA

I---III,orthopedic surgery.

BISbetween50 and60. ‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye opening, orientationintime andplaceand PACUdischarge. Luginbühl

etal. (2003)3

2B 2 160/160 80/80 >18years,

gynecological surgery.

BISbetween45 and55.

Anesthesiawas adjustedaccording toclinical parameters.

Timetotracheal extubation.

Ahmadetal. (2003)4

1B 3 99/97 49/48 >18years,

gynecological surgery.

BISbetween50 and60.

Anesthesiawas adjustedaccording toclinical parameters.

Timeforhospital discharge.

Bas¸aretal. (2003)5

2B 0 60/60 30/30 >18years,ASAIor II,abdominal surgery.

BISbetween40 and60. ‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Timeofeye openingupon verbalcommand.

Puriand Murthy (2003)6

2B 2 30/30 14/16 >18years,

myocardial revascularization orvalve replacementwith cardiopulmonary bypass,18---70 years.

BISbetween45 and55. ‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Timeofeye openingupon verbalcommand andextubation, intraoperative memory.

Kreueretal. (2003)7

2B 2 120/120 40/40 >18years,ASA I-III,orthopedic surgery.

BIS50andinthe last15minof60.

Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye openingand extubation. Mylesetal.

(2004)8

1B 5 2.503/2.463 1.225/1.238 >18yearswithat leastonehighrisk factorto intraoperative awakening.

BISbetween40 and60.

Monitorturnedoff. Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye opening,timefor dischargefrom PACUand intraoperative memory. Bruhnetal.

(2005)9

2B 2 200/200 71/58 >18years,ASA I-III.

BISof50.Inthe last15minBISof 60. Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye openingand extubation,PONV andintraoperative memory. Kreueretal.

(2005)10

1B 4 120/120 40/40 >18years,ASA I-III,orthopedic surgery.

BIS50andinthe last15minchange to60. Anesthesiawas adjustedaccording toclinical parameters. Timefor spontaneouseye opening, extubationand timeforleaving operationroom. Vretzakisetal.

(2005)11

1B 3 130/121 36/44 >18years,

myocardial revascularization orvalve replacementwith cardiopulmonary bypass,ejection fraction>45%.

BISunder60. Anesthesiawas adjustedaccording toclinical parameters.

(5)

Table2 (Continued)

RCT EL J R/A I/C P I C O

Aiméetal. (2006)12

2B 1 140/125 34/54 Agebetween18

and80years,ASA I-III,urologic, orthopedic, abdominaland gynecological surgery.

BISbetween40 and60.

‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Timefor spontaneouseye openingand traqueal extubation.

Ibraheimetal. (2008)13

2B 0 30/30 15/15 >18years,morbid obese,gastric bandsurgery.

BISbetween40 and60.

Anesthesiawas adjustedaccording toclinical parameters

Timeofeye openingupon verbalcommand, timefor extubationand dischargefrom PACU. Kamaletal.

(2009)14

2B 1 60/57 29/28 >18years,ASA

I-III,abdominal surgery

BISbetween50 and60.

‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Timefor spontaneouseye opening, extubation, orientationintime andplace,leaving operatingroom, dischargefrom PACUand intraoperative memory. Zhangetal.

(2011)15

1B 5 5.309/5.228 2.919/2.309 >18years,total intravenous anesthesia

BISbetween40 and60.

‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Intraoperative memory.

Chanetal. (2013)16

1B 3 921/902 450/452 >60years,elective non-cardiac surgery.

BISbetween40 and60.

Anesthesiawas adjustedaccording toclinical parameters.

Timefor spontaneouseye opening,timefor dischargefrom PACU,cognitive dysfunctioninthe postoperative period(oneweek andthreemonths later)and delirium. Radtkeetal.

(2013)17

1B 3 1.277/1.155 575/580 >60years BISbetween40 and60.

‘‘Blinded’’ monitor. Anesthesiawas adjustedaccording toclinical parameters.

Cognitive dysfunctioninthe postoperative period(oneweek andthreemonths later)and delirium. ASA,AmericanSocietyofAnesthesiologistsPhysicalStatus;RCT,RandomizedClinicalTrial;EL,EvidenceLevel;J,Jadadscore;R/A, patientsrandomizedandanalyzed;I/C,interventiongroup/controlgroup;P,population;I,intervention;C,controlorcomparison;O, outcome.

spontaneouseyeopeningof0.28min(95%CI−0.75,0.20).

However, the statistically significant difference was lost (Fig.2).

The time for eye opening upon verbal command is

countedfromtheendof lastsuture,when theinhaled or

intravenous anesthetic is discontinued and the patient is

askedtoopenhiseyes.Therewasareductionintimetoeye openingatverbalcommandof0.63min(95%CI−1.30,0.05),

withan I2=67%,withnostatisticallysignificant difference

(Fig.3).

The use of BIS reduced 1.18min in the time of

tra-cheal extubation(95% CI −1.65, −0.70), withan I2=79%.

In sensitivity analysis, when the study Kreuer et al.7

was removed, the time to tracheal extubation reduced

0.87min (95% CI −1.36, −0.38), with an I2=59%,

main-taining, therefore, a statistically significant difference (Fig.4).

Thecombinationofthreestudies1,2,14demonstratedthat thetimefororientationintimeandplacereduced3.08min (95%CI−3.70,−2.45)withanI2=73%.Insensitivity

analy-sis,whenthestudyNelskyläetal.1wasremovedwehavea reductionof3.76min(95%CI−4.55,−2.97)withanI2=0%,

maintaining,therefore,astatisticallysignificantdifference (Fig.5).

WhenusingtheBIS,thetimeforthepatienttobeable

toget outofthe operatingroomandgotoPACUreduced

2.93min (95%CI−3.68,−2.18),withan I2=92%.In

(6)

Table3 Full-textarticlesexcludedwithreasons.

Article Reasonofexclusion

Sebeletal.(1997)18 Beforeincisiontetanusstimulationwasappliedtotheulnarnerve.Anypresenceof

movement,anesthesiawasdeepened.Intheabsenceofmovement,anesthesiawas maintained.Afterincisionanymovementwasconsideredforthedeepeningofanesthesia. Thestudygoesoutoffocus---BISinterventioncomparedtothecontrolgroup(consciousness guidedbyclinicalparametersonly).

Yli-Hankalaetal.(1999)19 Thedataexpressionoftheoutcomeswasmadeinmedians.

Mietal.(1999)20 PatientsweremonitoredwithBISandoutcomeswereanalyzedduetodifferentanesthetic

regimens.Thestudygoesoutoffocus---BISinterventioncomparedtothecontrolgroup (consciousnessguidedbyclinicalparametersonly).

Nakayamaetal.(2002)21 AllpatientsweremonitoredwithBISandoutcomeswereanalyzedduetodifferentanesthetic

regimens(onlypropofolorpropofolandfentanyl).Thestudygoesoutoffocus---BIS interventioncomparedtothecontrolgroup(consciousnessguidedbyclinicalparameters only).

Lehmannetal.(2002)22 AllpatientsweremonitoredwithBISandanalyzedoutcomesresultingfromdifferent

anesthetictechniques(withmanualpropofolinfusionvs.propofolinTargetControlled Infusion---TCI).Thestudygoesoutoffocus---BISinterventioncomparedtothecontrolgroup (consciousnessguidedbyclinicalparametersonly).

Paventietal.(2002)23 AllpatientsweremonitoredwithBISandanalyzedoutcomesresultingfromdifferent

anesthetictechniques(manualpropofolinfusionvs.propofolinTCI).Thestudygoesoutof focus---BISinterventioncomparedtothecontrolgroup(consciousnessguidedbyclinical parametersonly).

Lehmannetal.(2003)24 AllpatientsweremonitoredwithBIS(groupBIS50andgroupBIS40).Thestudygoesoutof

focus---BISinterventioncomparedtothecontrolgroup(consciousnessguidedbyclinical parametersonly).

Yamaguchietal.(2003)25 AllpatientsweremonitoredwithBISandanalyzedoutcomesresultingfromdifferent

anestheticdrugsandtechniques(propofolgroup/ivinductionandsevofluranegroupwith inhalationalinductioninadultbythevitalcapacitytechnique).Thestudygoesoutoffocus ---BISinterventioncomparedtothecontrolgroup(consciousnessguidedbyclinicalparameters only).

Buyukkocaketal.(2003)26 AllpatientsweremonitoredwithBISandoutcomeswereanalyzedduetodifferentanesthetic

drugs,fourdifferentmethodsofsedationassociatedwithtopicalanesthesia.Thestudygoes outoffocus---BISinterventioncomparedtothecontrolgroup(consciousnessguidedby clinicalparametersonly).

Forestieretal.(2003)27 AllpatientsweremonitoredwithBISandanalyzedfivegroupswithdifferentconcentrationsof

sufentanil.Thestudygoesoutoffocus---BISinterventioncomparedtothecontrolgroup (consciousnessguidedbyclinicalparametersonly).

Schneideretal.(2003)28 AllpatientsweremonitoredwithBISandanalyzedfourdifferentanestheticregimens.The

studygoesoutoffocus---BISinterventioncomparedtothecontrolgroup(consciousness guidedbyclinicalparametersonly).

Schneideretal.(2003)29 AllpatientsweremonitoredwithBISandanalyzedtwodifferentanestheticregimens.The

studygoesoutoffocus---BISinterventioncomparedtothecontrolgroup(consciousness guidedbyclinicalparametersonly).

Liu(2004)30 Meta-analysis.Thecriteriaforinclusioninthesystematicreviewwererandomizedcontrolled

trials.

Baueretal.(2004)31 AllpatientsweremonitoredwithBISandanalyzedtwodifferentanestheticregimens(TCIvs.

manualpropofolinfusion).TheBISwasusedbutisnotdescribedwhetheritwasblinded.The studygoesoutoffocus---BISinterventioncomparedtothecontrolgroup(consciousness guidedbyclinicalparametersonly).

Bestasetal.(2004)32 All50patients(twogroupsof25)weremonitoredwithBISandwereblinded,withanalysisof

twodifferentanestheticregimes.Thestudygoesoutoffocus---BISinterventioncomparedto thecontrolgroup(consciousnessguidedbyclinicalparametersonly).

Boztugetal.(2006)33 Articlenotfound.

Purietal.(2007)34 AllpatientsweremonitoredwithBIS,withanalysisoftwodifferenttypesofpropofolinfusion.

(7)

Table3 (Continued)

Article Reasonofexclusion

Lindholmetal.(2008)35 ThepaperanalyzesthedegreeofproficiencyinhandlingtheBISbynurses’anesthetists.The

studygoesoutoffocus---BISinterventioncomparedtothecontrolgroup(consciousness guidedbyclinicalparametersonly).

Avidanetal.(2008)36 Inthecontrolgroup,anesthesiawasmaintainedwithBIS‘‘blinded’’butwithanexpired

fractionof0.7---1.3minimumalveolarconcentrationofinhaledanesthetic.

Bejjanietal.(2009)37 AllpatientsweremonitoredwithBISwithmemoryprocessinganalysis.Thestudygoesoutof

focus--- BISinterventioncomparedtothecontrolgroup(consciousnessguidedbyclinical parametersonly).

Delfinoetal.(2009)38 AllpatientsweremonitoredwithBISorcerebralstateindex,withanalysisofpropofolinfusion

withthesetwotypesofmonitoring.Thestudygoesoutoffocus---BISinterventioncompared tothecontrolgroup(consciousnessguidedbyclinicalparametersonly).

Kerssensetal.(2009)39 Studyofintraoperativememoryandretrievalofwordsheardduringthetrans-operative,

throughmemorytestspostoperatively.

Mashouretal.(2009)40 Cohortstudy.Thecriteriaforinclusioninthesystematicreviewwererandomizedcontrolled

trials.

Satishaetal.(2010)41 Cohortstudy.Thecriteriaforinclusioninthesystematicreviewwererandomizedcontrolled

trials.

Meybohmetal.(2010)42 Protocolstudy.Thecriteriaforinclusioninthesystematicreviewwererandomizedcontrolled

trials.

Leslieetal.(2010)43 Retrospectivecohortstudy.Thecriteriaforinclusioninthesystematicreviewwere

randomizedcontrolledtrials.

Avidanetal.(2009)44 Protocolstudy.Thecriteriaforinclusioninthesystematicreviewwererandomizedcontrolled

trials.

Ellerkmannetal.(2010)45 Inhalationorintravenousanesthesia,complementedbyregionalanesthesia(combined

anesthesia).Thestudygoesoutoffocus---BISinterventioncomparedtothecontrolgroup (consciousnessguidedbyclinicalparametersonly).

Yufuneetal.(2011)46 The38patientsweremonitoredwithBISandoutcomeswereanalyzedduetodifferent

anestheticregimens,aswellasdifferentconcentrationsofremifentanil.Thestudygoesout offocus---BISinterventioncomparedtothecontrolgroup(consciousnessguidedbyclinical parametersonly).

Liuetal.(2011)47 AllpatientsweremonitoredwithBISandoutcomeswereanalyzedduetodifferentanesthetic

regimens,targetcontrolledinfusionofpropofolvs.closed-loopmanagement.Thestudygoes outoffocus---BISinterventioncomparedtothecontrolgroup(consciousnessguidedby clinicalparametersonly).

Avidanetal.(2011)48 Thecontrolgroupwasadjustedformaintaininganexpiredfractionof0.7---1.3minimum

alveolarconcentrationofinhaledanesthetic.

Aiméetal.(2012)49 The102patientsweremonitoredwithBISorEntropy,inbothgroups,thevalueswereblinded,

andanesthesiawasconductedbyclinicalparameters.Thestudygoesoutoffocus---BIS interventioncomparedtothecontrolgroup(consciousnessguidedbyclinicalparameters only).

Mashouretal.(2012)50 Thecontrolgroupwasblinded,butadjustedtoaminimumalveolarconcentrationofinhaled

anestheticbyage.

Persecetal.(2012)51 Theresultsofthisstudycannotbemeta-analyzedastheyprovidenostandarddeviation.

Fritzetal.(2013)52 Retrospectivecohortstudy.Thecriteriaforinclusioninthesystematicreviewwere

randomizedcontrolledtrials.

Villafrancaetal.(2013)53 Retrospectivecohortstudy.Thecriteriaforinclusioninthesystematicreviewwere

randomizedcontrolledtrials.

BIS,bispectralindex.

haveareductionof4.89min(95%CI−5.95,−3.83)withan

I2=0%, maintaining,therefore, statisticallysignificant

dif-ference(Fig.6).

The timefor patientstoachieve thedischarge criteria

inthe PACU(Aldrete-Kroulikmodified index)wasreduced

4.05min (95% CI−7.23,−0.87), withI2=91%.In

sensitiv-ity analysis, when removed the study Ibraheim et al.,13

wehaveareductionof22.35min(95%CI−31.01,−13.69)

withI2=20%,maintainingstatisticallysignificantdifference

(Fig.7).

Therewasnostatisticallysignificantdifferencebetween theinterventionandcontrolintheevaluationofthe neces-sarytimetohospitaldischarge(95%CI,−22.08,30.52)with

(8)

Study or Subgroup

Nelskylä KA 2001

Nelskylä KA 2001 Wong J 2002

Wong J 2002 Kreuer S 2003

Kreuer S 2003 Kreuer S 2005

Kreuer S 2005 Aimé I 2006

Aimé I 2006 Kamal NM 2009

Kamal NM 2009

Total (95% CI)

Total (95% CI)

Heterogeneity: Chi2=34.57, df=6 (P<.00001); I2=83%

Heterogeneity: Chi2=2.29, df=5 (P=.81); I2 = 0% Test for overall effect: Z=2.64 (P=.008)

Test for overall effect: Z=1.13 (P=.26)

275

235 241

281 100.0%

100.0% Bruhn J 2005

Bruhn J 2005

5

4

3.5 2.9 40 9.3 5.2 40

3.5 2.9 40 9.3 5.2 40

5.6 2.5 58

4.7 2.2 40

3.9 54

1.9 28

–10 –5 0 5 10

–10 –5 0 5 10

58 40 54 28 8

4.4 71 3.4

2.1 40

4.1 34

1.6 29

5.9

5.6 2.5 71

3.4 5.9 4.2

4.7 2.2

2.1 40

4.2 7.6

3.9 8

4.1 34

7.6 4.1

1.9 4.4

1.6 29

4.1

2.1 29

5 32 5

4.9 3.4 31

4 2.1 29 4.9 3.4 31

2 30

5 5 32 5 2 30

6.1% 2001

2002

2003 2005 2005

2006 2009

2001 2002 2003 2005 2005 2006 2009 10.6%

6.3% 20.5%

24.0% 7.1% 25.5%

6.5% 11.3% 0.0% 21.9% 25.6% 7.6% 27.2%

0.00 [–1.87, 1.87] –0.90 [–2.32, 0.52]

–5.80 [–7.65, –3.95] 0.30 [–0.72, 1.32] –0.50 [–1.44, 0.44]

–0.40 [–2.13, 1.33] –0.30 [–1.21, 0.61]

0.00 [–1.87, 1.87] –0.90 [–2.32, 0.52] –5.80 [–7.65, –3.95] 0.30 [–0.72, 1.32] –0.50 [–1.44, 0.44] –0.40 [–2.13, 1.33] –0.30 [–1.21, 0.61] –0.62 [–1.08, –0.16]

–0.28 [–0.75, 0.20]

Mean SDTotal Mean SD Total Weight Year

Year

IV, Fixed, 95% CI IV, Fixed, 95% CI

BIS Control Mean difference

Study or Subgroup Mean SDTotal Mean SD Total Weight IV, Fixed, 95% CI

BIS Control Mean difference

Mean difference

IV, Fixed, 95% CI Mean difference

BIS Control BIS Control

Figure2 Timeforspontaneouseyeopening(min).

TheincidenceofPONVwaslowerinanesthesiaconducted

withBIS,withariskreductionof12%(95%CI−0.22,−0.01)

withI2=61%,whichwasstatisticallysignificant(Fig.9).

Therewasnoriskreductionofcognitivedisordersinthe

post operatorywith 1 week after extubation, in patients

usingBIS(95%CI,−0.06,0.01,I2=0%).Therewasno

statis-ticallysignificant differencebetweentheinterventionand control(Fig.10).

The cognitivedisordersaftersurgeryat 3monthsafter

extubationhadariskreductionof3%(95%CI−0.05,−0.00),

andI2=52%,whichwasstatisticallysignificant(Fig.11).

There was a 6% reduction in the risk of delirium in

thepost operatoryin patients monitoredwithBIS(95% CI

−0.10, −0.03) I2=11%, which was statistically significant

(Fig.12).

TheuseofBIShadariskreductionof1%forthe intraoper-ativememory(Recall),astatisticallysignificantdifference (−0.01[95%CI,−0.01,−0.00])withI2=0%.The

intraoper-ativememoryis the awakeningconfirmedby the patient.

Itwasnotmade adifferentiation ofstudies withpatients

classified as low or high risk for intraoperative memory

(Fig.13).

Discussion

The use of monitoring with the BIS showed benefits by

reducingthetimetoextubationin0.87min,orientationin

timeandplacein 3.76min and leavingoperating roomin

4.89min.Patientshadareductionin22.35mintoreachthe

criteriafor PACU discharge. The combined results of the

studiesshowed thatthe incidenceof PONV riskreduction

of12%inpatientsBISmonitoring.

Cognitive disorders in postoperative patients with 1

week after extubation did not show statistically

signifi-cantdifference.However,therewasa3%reductioninthe

risk of cognitive disorders in the postoperative patients

Study or Subgroup

Total (95% CI) 59 61 100.0% –0.63 [–1.30, 0.05]

BIS Control Mean

Basar H 2003 8.25

18.5

6.8 2.1 15 8.66

2.6 15 15.9%

11.5 14 28 16 0.5%–9.50 [–19.00, 0.00]

–1.86 [–3.55, 0.17] 15

1.8 30 8.59 1 30 83.6% –0.34 [–1.08, 0.40] 2003

2008 2003 Puri GD 2003

Ibraheim O 2008

Heterogeneity: Chi2=5.97, df=2 (P=.05); I2=67%

–10 –5 0 5 10

Test for overall effect: Z=1.82 (P=.07)

Mean

SDTotal SDTotal Weight IV, Fixed, 95% CIYear IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

(9)

Study or Subgroup

Total (95% CI)

Total (95% CI)

355 315 361 321 100.0% 100.0%

–1.18 [–1.65, –0.70]

–0.87 [–1.36, –0.38]

Nelskylä KA 2001 2

6.8 4.6 40 10.5 5.9 40 4.2%

4.4% 3.0% 6.5% 9.8% 21.8% 2.6% 7.2% 17.4% 40 16 40 40 58 54 15 28 6.1 3.2 5.3 4.4 2.4 9 2.9 2.3 8.3 6 9.7 5.4 6.3 14.2 11.8 4.8 4.1 40 14 40 40 71 34 15 29 4.3 2.9 2.2 3.5 5.1 2 2.1 6.5 7.2 4.1 4.4 6.6 11.1 9.26 4.3

2 32 3 2

2

6.8

4.6

40 10.5

5.9

6.1 3.2 5.3 4.4 2.4 9 2.9 2.3 8.3 6 9.7 5.4 6.3 14.2 11.8 4.8 4.1 40 14 40 40 71 34 15 29 4.3 2.9 2.2 3.5 5.1 2 2.1 6.5 7.2 4.1 4.4 6.6 11.1 9.26 4.3

2

32 3

2 30 40 40 16 40 40 58 54 15 28 30 23.0% 24.6% 4.5% 4.7% 3.2% 0.0% 10.5% 23.4% 2.8% 18.6%

–10 –5 0 5 10

7.7%

–1.00 [–2.00, –0.00]

–1.00 [–2.00, –0.00] –3.70 [–6.02, –138]

–3.70 [–6.02, –138] –1.80 [–4.08, 0.48] 1.20 [–1.54, 3.94]

–5.60 [ –7.47, –3.73] –1.00 [–2.52, 0.52]

0.30 [–0.72, 1.32] –3.10 [–6.05, –0.15] –2.54 [–4.32, –0.76] –0.50 [–1.64, 0.64]

2001 2003 2003 2003 2003 2005 2005 2006 2008 2009 2001 2003 2003 2003 2003 2005 2005 2006 2008 2009 –1.80 [–4.08, 0.48]

1.20 [–1.54, 3.94]

–5.60 [ –7.47, –3.73]

–1.00 [–2.52, 0.52] 0.30 [–0.72, 1.32]

–3.10 [–6.05, –0.15] –2.54 [–4.32, –0.76]

–0.50 [–1.64, 0.64] Luginbühl M, 2003 (a)

Luginbühl M, 2003 (b) Puri GD 2003 Kreuer S 2003 Kreuer S 2005 Bruhn J 2005 Aimé I 2006 Ibraheim O 2008 Kamal NM 2009

Nelskylä KA 2001 Luginbühl M, 2003 (a)

Luginbühl M, 2003 (b)

Puri GD 2003 Kreuer S 2003

Kreuer S 2005 Bruhn J 2005

Aimé I 2006 Ibraheim O 2008

Kamal NM 2009

Heterogeneity: Chi2=42.58, df=9 (P<.00001); I2=79%

–10 –5 0 5 10

Test for overall effect: Z=4.83 (P<.00001)

Heterogeneity: Chi2=19.65, df=8 (P=.01); I2=59% Test for overall effect: Z=3.45 (P=.0006)

Mean SD TotalMean SDTotal Weight IV, Fixed, 95% CI Year IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

Study or Subgroup MeanSD TotalMeanSDTotal Weight IV, Fixed, 95% CIYear IV, Fixed, 95% CI

BIS

Control Mean difference Mean difference

BIS Control

BIS Control

Figure4 Timetotrachealextubation(min).Luginbühl(2003)studiedwithinasingleoutcome,twodifferentanestheticregimens withpropofol(a)anddesflurane(b).

3 months after extubation. There was a 6% reduction in

theriskof deliriumincidenceof postoperativeinpatients

using BIS monitoring. In addition, the memory of the

intraoperative risk had a reduction of 1% after using

BIS.

The 17 studies selected by the pre-established

crite-riashowedaheterogeneitythatwassoonnoticed.Factors

related toanesthetic technique,the patientand the

sur-gical procedure wereobserved. Studiesthat analyzed the

consumptionofanesthetics showednostandardized

meas-Study or Subgroup

Mean

SDTotal MeanSDTotal Weight IV, Fixed, 95% CIYear IV, Fixed, 95% CI

BIS

Control Mean difference Mean difference

Study or Subgroup Mean SDTotal MeanSDTotal Weight IV, Fixed, 95% CIYear IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

Nelskylä KA 2001 Wong J 2002

6 9.5 7.4 2 3.1 1.5 32 29 29 3 2 3.8 13.1 11.2 1.9

30 38.8% –2.00 [–3.00, –1.00] –3.60 [–5.35, –1.85] –3.80 [–4.69, –2.91]

2001 2002 2009 2001 2002 2009 12.6% 48.6%

–10 –5 0 5 10

28 31 Kamal NM 2009

Nelskylä KA 2001 Wong J 2002

2 9.5 7.4 2 3.1 1.5 32 29 29 3 2 3.8 13.1 11.2 1.9

30 0.0% –2.00 [–3.00, –1.00] –3.60 [–5.35, –1.85] –3.80 [–4.69, –2.91] 20.6%

79.4% 28 31 Kamal NM 2009

Total (95% CI) 90 89 100.0%–3.08 [–3.70, –2.45]

Heterogeneity: Chi2=7.36, df=2 (P=.03); I2=73% Test for overall effect: Z=9.71 (P<.00001)

Total (95% CI) 58 59 100.0% –3.76 [–4.55, –2.97]

Heterogeneity: Chi2=.04, df=1 (P=.84); I2=0%

Test for overall effect: Z= 9.28 (P<.00001) –10 –5 0 5 10

BIS Control BIS Control

(10)

Study or Subgroup Mean SDTotalMean SDTotal Weight IV, Fixed, 95% CI Year IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

40 40

40

40 Kreuer S 2003

Kreuer S 2005

9.4 8.4 7

9.4 8.4 7

1.9 2.4 3.2

1.9 2.4 3.2

29

40

40 29

14.1 9.4 12.4

14.1 9.4 12.4

2.8 2.4 5.7

2.8 2.4 5.7

–4.70 [–5.95, –3.45] –1.00 [–2.05, 0.05] –5.40 [–7.43, –3.37]

2009 2005 2003

2009 2005 2003

–4.70 [–5.95, –3.45] –1.00 [–2.05, 0.05] –5.40 [–7.43, –3.37] 35.9%

72.5% 0.0% 27.5% 50.5% 13.6%

28 40 40 28 Kamal NM 2009

Kreuer S 2003

Kreuer S 2005 Kamal NM 2009

Total (95% CI) 109 108100.0% –2.93 [–3.68, –2.18]

Heterogeneity: Chi2=26.39, df=2 (P<.00001); I2=92% Test for overall effect: Z=7.68 (P<.00001)

Total (95% CI) 69 68 100.0% –4.89 [–5.95, –3.83]

Heterogeneity: Chi2=.33, df=1 (P<.56); I2=0%

Test for overall effect: Z=9.03 (P<.00001)

Study or Subgroup Mean SDTotalMean SD Total Weight IV, Fixed, 95% CI Year IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

–10 –5 0 5 10

–10 –5 0 5 10

BIS Control BIS Control

Figure6 Timeforleavingoperationroom(min).

Wong J 2002 111 30 29 123 48 31 2.5% –12.00 [–32.12, 8.12]

Wong J 2002 111 30 29 123 48 31 18.5% –12.00 [–32.12, 8.12] 86.5%

15 4.81 31 15 4.74

29.8 –1.20 [–4.62, 2.22]

Ibraheim O 2008

0.0% 15 4.81 31 15 4.74

29.8 –1.20 [–4.62, 2.22]

Ibraheim O 2008

11.0% 28 21.5 78.6 29 14.7

53.9 –24.70 [–34.29, –15.11]

2002 2008 2009

2002 2008 2009 Kamal NM 2009

81.5% 28 21.5 78.6 29 14.7

53.9 –24.70 [–34.29, –15.11]

Kamal NM 2009

Total (95% CI) 73 74 100.0% –4.05 [–7.23, –0.87]

Heterogeneity: Chi2=21.07, df=2 ( P<.0001); I2=91%

Test for overall effect: Z=2.50 (P=.01)

Total (95% CI) 58 59 100.0% –22.35 [–31.01, –13.69]

Heterogeneity: Chi2=1.25, df=1 ( P=.26); I2=20%

Test for overall effect: Z=5.06 (P<.00001)

Study or Subgroup Mean SDTotalMean SD Total Weight IV, Fixed, 95% CI Year IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

Study or Subgroup Mean SDTotalMean SDTotal Weight IV, Fixed, 95% CI Year IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

BIS Control

–100 –50 0 50 100

BIS Control

–100 –50 0 50 100

Figure7 TimefordischargefromPACU(min).

uresthatenabledtheselection ofatleasttwostudiesfor

themeta-analysis.

The study Ibraheim et al.13 involved morbidly obese

patients. Three studies were conducted exclusively with

patientsover60yearsofage.2,16,17

Purietal.6andVretzakisetal.11studiedpatients under-goingcardiacsurgerywithextracorporealcirculation.

Mylesetal.8studiedpatientswithatleastonehigh-risk

factor for awakening with intraoperative memories (high

risk heart surgery, cesarean sections, hypovolemic shock,

rigidbronchoscopy,cardiovascularinstabilityandexpected hypotensionduringsurgery,lungdiseaseinadvancedstages, historicalofawakeningwithintraoperativememories,

dif-ficult airway, high consumption of alcohol, chronic use

Study or Subgroup Mean SDTotal Mean SD Total Weight IV, Fixed, 95% CI IV, Fixed, 95% CI

BIS Control Mean difference Mean difference

Nelskylä KA 2001

Ahmad S 2003

306 85 32 298 124 30 24.4%

203 78 49 200 74 48 75.6%

8.00 [–45.26, 61.26]

3.00 [–27.25, 33.25]

Year

2001

2003

Total (95% CI)

Heterogeneity: Chi2=0.03, df=1 (P=.87); I2=0%

Test for overall effect: Z=0.31 (P=.75)

81 78 100.0% 4.22 [–22.08, 30.52]

–100 –50 0 50 100

BIS Control

(11)

Study or Subgroup EventsTotal EventsTotal Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CI

BIS Control Risk difference Risk difference

Nelskylä KA 2001 Bruhn J 2005

5 32 12 30 32.7%

6 71 8 58 67.3%

–0.24 [–0.46, –0.03] –0.05 [–0.16, 0.06]

Year

2001 2005

Total (95% CI)

Total events

Heterogeneity: Chi2=2.59, df=1 (P=.11); I2=61% Test for overall effect: Z=2.22 (P=.03)

103

11

88

20

100.0% –0.12 [–0.22, –0.01]

–1 –0.5 0 0.5 1

BIS Control

Figure9 Postoperativenauseaandvomiting(PONV)---n(%).

Study or Subgroup Events Total Events Total Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CI

BIS Control Risk difference Risk difference

Chan 2013 Radtke 2013

98 70

450 104 452 43.9% –0.01 [–0.07, 0.04]

575 90 580 56.1% –0.03 [–0.07, 0.01]

Total events

Heterogeneity: Chi2=.39, df=1 (P=.53); I2=0% Test for overall effect: Z=1.45 (P=.15)

168 194

–1 –0.5 0 0.5 1

BIS Control

Total (95% CI) 1025 1032 100.0% –0.02 [–0.06, 0.01]

Figure10 Cognitivedisordersinthepostoperativeperiod(1weekafterextubation)---n(%).

Study or Subgroup Events Total Events Total Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CI

BIS Control Risk difference Risk difference

Chan 2013 Radtke 2013

46 21

450 66 452 43.9% –0.04 [–0.09, –0.00]

575 28 580 56.1% –0.01 [–0.03, 0.01]

Total events

Heterogeneity: Chi2=2.08, df=1 (P=.15); I2=52% Test for overall effect: Z=2.21 (P=.03)

67 94

–0.5 –0.25 0 0.25 0.5

BIS Control Total (95% CI) 1025 1032 100.0% –0.03 [–0.05, –0.00]

Figure11 Cognitivedisordersinthepostoperativeperiod(3monthsafterextubation)---n(%).

Study or Subgroup EventsTotal EventsTotal Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CI

BIS Control Risk difference Risk difference

Chan 2013 Radtke 2013

70 95

450 109 452 43.9% –0.09 [–0.14, –0.03] 575 28 580 56.1% –0.05 [–0.09, –0.00]

Year

2013 2013

Total events

Heterogeneity: Chi2=1.12, df =1 (P=.29); I2=11%

Test for overall effect: Z=3.74 (P=.0002)

165 233

–1 –0.5 0 0.5 1

BIS Control

Total (95% CI) 1025 1032 100.0% –0.06 [–0.10, –0.03]

Figure12 Postoperativedelirium---n(%).

Study or Subgroup Events Total Events Total Weight M-H, Fixed, 95% CI M-H, Fixed, 95% CI

BIS Control Risk difference Risk difference

Puri GD 2003 Myles PS 2004 Bruhn J 2005 Kamal NM 2009 Zhang C 2011

0 2 0

14 1 16 0.4% –0.06 [–0.23, 0.10] 1225

71 29 2919 0 4

11 0 0 15

1238 58 28 2309

31.4% 1.6% 0.7% 65.8%

–0.01 [–0.01, –0.00] 0.00 [–0.03, 0.03] 0.00 [–0.07, 0.07] –0.01 [–0.01, –0.00]

2003 2004 2005 2009 2011

Total events

Heterogeneity: Chi2=1.04, df=4 (P=.90); I2=0%

Test for overall effect: Z=3.73 (P=.0002)

6 27

–0.1 –0.05 0 0.05 0.1

BIS Control

Total (95% CI) 4258 3649 100.0% –0.01 [–0.01, –0.00]

Year

(12)

of benzodiazepines or opioids and therapy with protease inhibitors).

The outcomes analyzed with continuously variable

relatedtothe timeof recovery anddischarge ofpatients

were:timeforspontaneouseyeopening,timeforeye

open-ing upon verbal command, time for extubation, time for

orientation in time and place, time for leaving operating

room, timefor PACUdischarge and time for hospital

dis-charge.

The outcomes of dichotomous variable, related to

adverseeventswerePONV,cognitivedisordersinthe

post-operative 1 week after extubation, cognitive disordersin

thepostoperative3monthsafterextubation,postoperative

deliriumandintraoperativememory.

Some primary studies contributed only one outcome

analyzed.3---5,11,15

The individualizationof outcomesderivedfromstudies

involvingbalancedanesthesiaortotalintravenous

anesthe-siawasnotmade.

Clinically,thecostofimplementationofBISmonitoring canbejustifiedbyallowingadvantagesinthemaintenance ofambulatorysurgeriesaswellasinthetechniquesofearly

awakening and especially it can reduce the incidence of

adverseevents.

The cost of thedisposable electrodeis a causeof

dis-cussionaboutthevalueinuseofBIS.Thus,itisimportant

the active participation of professionals, primarily with

healthadministrators,indevelopingapolicyplanthat opti-mizeresourcesandgivegreatersafetyandcomfortforthe patients.

Sofar,thereisnogoldstandardtospantheentire spec-trumofanestheticeffectonthecentralnervoussystem,and theBISisundoubtedlythemoststudied,butisoneofmany

monitorsderivedfromEEGusednowadays.Monitoringthe

depthof anesthesiaasnewtechnologyisin itsbeginning. Thenewboundaryistheindividualizationofmonitoringthe hypnoticanditseffectsonthecentralnervoussystem.

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

References

1.NelskyläKA,Yli-HankalaAM,PuroPH,etal.Sevoflurane titra-tionusing bispectral index decreasespostoperativevomiting inphaseIIrecovery afterambulatory surgery.Anesth Analg. 2001;93:1165---9.

2.WongJ,SongD,BlanshardH,etal.Titrationofisofluraneusing BISindeximprovesearlyrecoveryofelderlypatientsundergoing orthopedicsurgeries.CanJAnaesth.2002;49:13---8.

3.LuginbühlM,WüthrichS,Petersen-FelixS,etal.Different bene-fitofbispectalindex(BIS)indesfluraneandpropofolanesthesia. ActaAnaesthesiolScand.2003;47:165---73.

4.AhmadS,YilmazM,MarcusRJ,etal.Impactofbispectralindex monitoringonfasttrackingofgynecologicpatientsundergoing laparoscopicsurgery.Anesthesiology.2003;98:849---52. 5.Bas¸arH, Ozcan S, Buyukkocak U, et al. Effect ofbispectral

indexmonitoringonsevofluraneconsumption.EurJ Anaesthe-siol.2003;20:396---400.

6.Puri GD, Murthy SS. Bispectral index monitoring in patients undergoingcardiacsurgeryundercardiopulmonarybypass.Eur JAnaesthesiol.2003;20:451---6.

7.Kreuer S, Biedler A, Larsen R, et al. Narcotrend moni-toring allows faster emergence and a reduction of drug consumptioninpropofol-remifentanilanesthesia. Anesthesiol-ogy.2003;99:34---41.

8.MylesPS,LeslieK,McNeilJ,etal.Bispectralindexmonitoringto preventawarenessduringanaesthesia:theB-Awarerandomised controlledtrial.Lancet.2004;363:1757---63.

9.BruhnJ,KreuerS,BischoffP,etal.BispectralindexandA-line AAIindexasguidancefordesflurane-remifentanilanaesthesia comparedwithastandardpracticegroup:amulticentrestudy. BrJAnaesth.2005;94:63---9.

10.KreuerS,BruhnJ,StrackeC,etal.Narcotrendorbispectral indexmonitoringduringdesflurane-remifentanilanesthesia:a comparisonwitha standardpractice protocol.AnesthAnalg. 2005;101:427---34.

11.VretzakisG,FerdiE,ArgiriadouH,etal.Influenceofbispectral indexmonitoringondecisionmakingduringcardiacanesthesia. JClinAnesth.2005;17:509---16.

12.Aimé I, VerroustN, Masson-Lefoll C, et al. Does monitoring bispectral indexor spectral entropy reducesevoflurane use? AnesthAnalg.2006;103:1469---77.

13.Ibraheim O, Alshaer A, Mazen K, et al. Effect of bispec-tral index (BIS) monitoring on postoperative recovery and sevofluraneconsumptionamongmorbidlyobesepatients under-goinglaparoscopicgastricbanding.MiddleEastJAnesthesiol. 2008;19:819---30.

14.KamalNM,OmarSH,RadwanKG,etal.Bispectralindex moni-toringtailorsclinicalanestheticdeliveryandreducesanesthetic drugconsumption.JMedSci.2009;9:10---6.

15.ZhangC,XuL,MaYQ,etal.Bispectralindexmonitoringprevent awarenessduringtotalintravenousanesthesia:aprospective, randomized,double-blinded,multi-centercontrolledtrial.Chin MedJ(Engl).2011;124:3664---9.

16.Chan MT, Cheng BC, Lee TM, et al. BIS-guided anesthesia decreasespostoperativedeliriumandcognitivedecline.J Neu-rosurgAnesthesiol.2013;25:33---42.

17.Radtke FM,FranckM, Lendner J,et al. Monitoringdepthof anaesthesiainarandomizedtrialdecreasestherateof postop-erativedeliriumbutnotpostoperativecognitivedysfunction.Br JAnaesth.2013;110Suppl.1:i98---105.

18.SebelPS,LangE,RampilIJ,etal.Amulticenterstudyof bispec-tral electroencephalogramanalysisfor monitoringanesthetic effect.AnesthAnalg.1997;84:891---9.

19.Yli-HankalaA,VakkuriA,AnnilaP,etal.EEGbispectralindex monitoringinsevofluraneorpropofolanaesthesia:analysisof directcostsandimmediaterecovery.ActaAnaesthesiolScand. 1999;43:545---9.

20.MiWD,SakaiT,SinghH,etal.Hypnoticendpointsvs.the bispec-tralindex,95%spectraledgefrequencyandmedianfrequency duringpropofolinfusionwithorwithoutfentanyl.EurJ Anaes-thesiol.1999;16:47---52.

21.Nakayama M, Ichinose H, Yamamoto S, et al. The effect of fentanyl on hemodynamic and Bispectral Index changes during anesthesia induction with propofol. J Clin Anesth. 2002;14:146---9.

22.LehmannA,BoldtJ,ThalerE,etal.BispectralIndexinpatients withtarget-controlledormanually-controlledinfusionof propo-fol.AnesthAnalg.2002;95:639---44.

23.PaventiS,SantevecchiA,PerilliV,etal.Effectsofremifentanil infusion BIS-titratedon earlyrecovery for obese outpatients undergoinglaparoscopiccholecystectomy.MinervaAnestesiol. 2002;68:651---7.

(13)

25.YamaguchiS,EgawaH,MishioM,etal.Bispectralmonitoring duringvital capacityrapidinhalationinduction with sevoflu-rane.JClinAnesth.2003;15:24---8.

26.Buyukkocak U, Ozcan S, Daphan C, et al. A compari-son of four intravenous sedation techniques and Bispectral Indexmonitoringinsinonasalsurgery.AnaesthIntensiveCare. 2003;31:164---71.

27.ForestierF,HirschiM,RougetP,etal.Propofolandsufentanil titration withtheBispectral Index to provide anesthesia for coronaryarterysurgery.Anesthesiology.2003;99:334---46. 28.SchneiderG,GelbAW,SchmellerB,etal.Detectionof

aware-ness in surgical patients with EEG-based indices-bispectral indexandpatientstateindex.BrJAnaesth.2003;91:329---35. 29.Schneider G, Elidrissi C, Sebel PS. Bispectral index-guided

administrationof anaesthesia:comparison between remifen-tanil/propofolandremifentanil/isoflurane.EurJAnaesthesiol. 2003;20:624---30.

30.Liu SS.Effectsof BispectralIndex monitoringonambulatory anesthesia.Anesthesiology.2004;101:311---5.

31.BauerM, Wilhelm W, Kraemer T, etal. Impact ofBispectral Indexmonitoringonstressresponseandpropofolconsumption inpatientsundergoingcoronaryarterybypasssurgery. Anesthe-siology.2004;101:1096---104.

32.BestasA, YasarMA,BayarMK,etal. Theeffectsoftwo dif-ferentanaesthesiatechniquesonbispectralindexvaluesand awarenessduringoff-pumpcoronaryarterybypassgrafting.J ClinMonitComput.2004;18:347---51.

33.Boztug N,BigatZ,Akyüz M,et al.Doesusing theBispectral Index(BIS)duringcraniotomyaffectthequalityofrecovery?J NeurosurgAnesthesiol.2006;18:1---4.

34.PuriGD,KumarB,AveekJ.Closed-loopanaesthesiadelivery sys-tem(CLADS)usingbispectralindex:aperformanceassessment study.AnaesthIntensiveCare.2007;35:357---62.

35.LindholmML,BrudinL,SandinRH.Bispectralindexmonitoring: appreciatedbutdoesnotaffectdrugdosingandhypnoticlevels. ActaAnaesthesiolScand.2008;52:88---94.

36.AvidanMS,ZhangL,BurnsideBA,etal.Anesthesiaawareness andtheBispectralIndex.NEnglJMed.2008;358:1097---108. 37.BejjaniG,LequeuxPY,SchmartzD,etal.Noevidenceof

mem-ory processingduringpropofol-remifentanil target-controlled infusionanesthesiawithBispectralIndexmonitoringincardiac surgery.JCardiothoracVascAnesth.2009;23:175---81. 38.DelfinoAE,CortinezLI,FierroCV,etal.Propofolconsumption

andrecoverytimesafterbispectralindexorcerebralstateindex guidanceofanaesthesia.BrJAnaesth.2009;103:255---9. 39.Kerssens C, Gaither JR, Sebel PS. Preserved memory

func-tion during Bispectral Index-guided anesthesia with sevoflu-rane for major orthopedic surgery. Anesthesiology. 2009; 111:518---24.

40.MashourGA,TremperKK,AvidanMS.Protocolforthe‘‘Michigan Awareness Control Study’’: a prospective, randomized, con-trolled trialcomparing electronic alertsbased on bispectral index monitoringor minimumalveolarconcentrationfor the prevention of intraoperative awareness. BMC Anesthesiol. 2009;9:7.

41.SatishaM, SandersGM, BadrinathMR, et al.Introduction of bispectralindexmonitoringinadistrictgeneralhospital operat-ingsuite:aprospectiveauditofclinicalandeconomiceffects. EurJAnaesthesiol.2010;27:196---220.

42.MeybohmP, GruenewaldM,Höcker J, etal. Correlationand agreementbetweenthebispectralindexvs.stateentropy dur-inghypothermic cardio-pulmonary bypass. Acta Anaesthesiol Scand.2010;54:169---75.

43.LeslieK,MylesPS,ForbesA,etal.TheeffectofBispectralIndex monitoringonlong-termsurvivalintheB-Awaretrial.Anesth Analg.2010;110:816---22.

44.AvidanMS,PalancaBJ,GlickD,et al.Protocol forthe BAG-RECALLclinicaltrial:aprospective,multi-center,randomized, controlledtrialtodeterminewhetherabispectralindex-guided protocolis superiorto ananesthesia gas-guided protocol in reducingintraoperativeawarenesswithexplicitrecallinhigh risksurgicalpatients.BMCAnesthesiol.2009;9:8.

45.EllerkmannRK, Soehle M, Riese G, et al. The Entropy Mod-uleandBispectralIndexasguidanceforpropofol-remifentanil anaesthesiaincombinationwithregionalanaesthesiacompared withastandardclinicalpracticegroup.AnaesthIntensiveCare. 2010;38:159---66.

46.YufuneS,Takamatsu I,MasuiK,et al.Effectofremifentanil onplasmapropofolconcentrationandbispectralindexduring propofolanaesthesia.BrJAnaesth.2011;106:208---14. 47.Liu N, Chazot T, Hamada S, et al. Closed-loop

coadmin-istration of propofol and remifentanil guided by Bispectral Index:arandomizedmulticenterstudy.AnesthAnalg.2011;112: 546---57.

48.AvidanMS,JacobsohnE,GlickD,etal.Preventionof intraoper-ativeawarenessinahigh-risksurgicalpopulation.NEnglJMed. 2011;365:591---600.

49.AiméI,GayatE,FermanianC,etal.Effectofageonthe com-parability ofbispectral and state entropy indices duringthe maintenanceofpropofol---sufentanilanaesthesia.BrJAnaesth. 2012;108:638---43.

50.MashourGA,ShanksA,TremperKK,etal.Preventionof intraop-erativeawarenesswithexplicitrecallinanunselectedsurgical population.Anesthesiology.2012;117:717---25.

51.PersecJ,PersecZ,KopljarM,etal.Effectofbispectralindex monitoringonextubationtimeand analgesic consumptionin abdominalsurgery:arandomisedclinicaltrial.SwissMedWkly. 2012;142:w13689.

52.FritzBA,RaoP,MashourGA,etal.Postoperativerecoverywith BispectralIndexversusanestheticconcentration-guided proto-cols.Anesthesiology.2013;118:1113---22.

Imagem

Table 2 shows the trials selected with the respective lev- lev-els of evidence, Jadad scale, number of patients randomized and analyzed, patient numbers in the intervention and  con-trol groups and PICO strategy
Table 2 Selected randomized clinical trials (RCT). RCT EL J R/A I/C P I C O Nelskylä et al
Table 3 Full-text articles excluded with reasons.
Figure 2 Time for spontaneous eye opening (min).
+4

Referências

Documentos relacionados

In the article ‘‘Addition of lidocaine to levobupivacaine reduces intrathecal block duration: randomized controlled trial’’ (estudo clínico randômico’’ (Rev Bras

Bispectral index monitoring prevent awareness during total intravenous anesthesia: a prospective, randomized, double-blinded, multi-center controlled trial. Bispectral index

Ropivacaine for unilateral spinal anesthesia: hyperbaric or hypobaric. Rev

Major abdominal surgeries in neonates are mostly performed under general anesthesia with endotracheal intubation, or general anesthesia with regional blockade.. However, gen-

Letter to the editor: Spinal subarachnoid hematoma after-spinal anesthesia: case report [Rev Bras Anestesiol 2016]. Carta à editora:

Letter to the editor: Spinal subarachnoid hematoma after-spinal anesthesia: case report [Rev Bras Anestesiol 2016].. Carta à editora:

The inclusion criteria included randomized, prospective or retrospective controlled trials in growing subjects with posterior crossbite; treated with maxillary expanders;

The search results were screened based on the following inclusion criteria: (i) the studies were randomized or quasi- randomized controlled clinical trials on patients with